Gentian Diagnostics ASA (GENT) Earnings Call Transcripts
About Gentian Diagnostics ASA
Gentian Diagnostics ASA (GENT) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on OB and is based in NO. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 20 calls on record spanning February 17, 2022 to October 20, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 20 Gentian Diagnostics ASA earnings call transcripts on record, spanning February 17, 2022 to October 20, 2026. Based on this history, Gentian Diagnostics ASA reports quarterly. The most recent call on file is dated October 20, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- GENT
- Exchange
- OB
- Country
- NO
- Sector
- Health Care
- Calls on record
- 20
- First call
- February 17, 2022
- Most recent
- October 20, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q3 FY2026 | Oct 20, 2026 | Read transcript → |
| Q2 FY2026 | Jul 9, 2026 | Read transcript → |
| Q1 FY2026 | May 6, 2026 | Read transcript → |
| Q4 FY2025 | Feb 11, 2026 | Read transcript → |
| Q3 FY2025 | Oct 23, 2025 | Read transcript → |
| Q1 FY2025 | May 7, 2025 | Read transcript → |
| Q4 FY2024 | Feb 12, 2025 | Read transcript → |
| Q3 FY2024 | Oct 31, 2024 | Read transcript → |
| Q2 FY2024 | Aug 29, 2024 | Read transcript → |
| Q1 FY2024 | Apr 30, 2024 | Read transcript → |
| Q4 FY2023 | Feb 9, 2024 | Read transcript → |
| Q3 FY2023 | Oct 26, 2023 | Read transcript → |
| Q2 FY2023 | Aug 24, 2023 | Read transcript → |
| Analyst/Investor Day | May 10, 2023 | Read transcript → |
| Q1 FY2023 | May 5, 2023 | Read transcript → |
| Q4 FY2022 | Feb 16, 2023 | Read transcript → |
| Q3 FY2022 | Oct 27, 2022 | Read transcript → |
| Q2 FY2022 | Aug 25, 2022 | Read transcript → |
| Q1 FY2022 | Apr 28, 2022 | Read transcript → |
| Q4 FY2021 | Feb 17, 2022 | Read transcript → |